Customereye

Nerve Renew

Supplements & Nutrition • United Statesnerverenew.com

Review data last updated .

Based on public reviews and response behavior.

Tip: Tap or click the ⓘ icons to learn how to read each section. Expand cards for evidence.

Overall Score

60/100
+14.8 vs. last month4.11 ★ average rating · 1,000 reviews

Competitive Performance Rank

Among fully-analyzed Supplements & Nutrition companies

#109of 301
Top 36% · Upper Half
#1 (best)#301 (worst)
#107Peer
#108Peer
#109This company
#110Peer
#111Peer

Overall Customer Sentiment

Above Average

56% of reviews positive, 41% negative

56%
positive
  • Positive56%
  • Neutral3%
  • Negative41%

Sentiment Balance

Covering July 2026 — 17 reviews, not the company's full review history.

positive
  • Positive
  • Neutral
  • Negative

Takeaway: Positive sentiment accounts for 53% of reviews in this period, with 47% negative and 0% neutral.

Sentiment Trend Over Time

Reviews (Count)

Showing 1,000 reviews across the months with enough data to chart reliably (min 3/month), most recent: July 2026.

Sentiment has been holding steady over the period shown.

Theme Distribution

Share of theme mentions

Delivery Shipping
20.7%
Onboarding
16.5%
Customer Support
13.4%
Pricing
12.2%
Loyalty
11.9%

Most feedback concerns Delivery Shipping.

The most common complaint theme is Pricing, making up 12.2% of all theme mentions.

Churn Signal Score

Rule-based: negative-review share, churn-intent phrases, and sentiment movement over time.

MEDIUM41/100
41/100
signal score
  • Built from a negative-review share of 40.9% across this company's analyzed reviews.
  • 5 reviews contain phrases that signal intent to leave, such as cancelling or switching provider.
  • Recent reviews are less negative than earlier ones, which pulls the signal down.

Reviewer Breakdown

Star split and recent-versus-earlier sentiment.

4.1avg rating
5
65.7%
4
8.9%
3
8.5%
2
4.1%
1
12.8%

Based on 1,000 analyzed reviews. Sentiment is improving: 81.4% of reviews in the last three months were positive, compared with 71.9% in the three months before that.

Unlock full insights

Sign up to view detailed data and analysis